Low testosterone and TRT: a complete guide for men in 2026


You typed "low testosterone" into a search bar for a reason. Maybe the energy is gone. Maybe sleep stopped working, or the gym stopped giving back. Here is the honest part most clinics skip past: those feelings are real, but they are not proof of anything yet. Low testosterone is a specific medical condition with a specific way of confirming it, and "I feel off" is the start of that conversation, not the end. So read on. We will untangle what is real, what is aging, and what a responsible plan actually looks like in 2026.
Short answer: Low testosterone (also called testosterone deficiency or hypogonadism) is when the body does not make enough testosterone and a man has symptoms because of it. It is confirmed with symptoms plus two low morning blood tests, not a feeling or a single number. Testosterone replacement therapy (TRT) can help men with a confirmed condition, never aging alone. Individual results vary.2, 3
- What low testosterone actually is, and why it is not the same as getting older
- How a clinician confirms it: symptoms plus two morning labs, never one number
- The 2026 treatment menu, from injections to gels to a newer oral option
- The real benefits and the real risks, stated plainly, including the 2025 FDA label change
Low testosterone is a real condition, not a vibe
Symptoms and repeat lab results need to be assessed together
How a clinician actually confirms low testosterone
A clinician considers symptoms and signs together with consistently low testosterone results, then repeats a morning fasting measurement to confirm. Additional tests can help identify the cause. A low number by itself does not establish that TRT is appropriate.3
What TRT can help with, stated honestly
TRT is intended to treat confirmed hypogonadism and its symptoms. It is not a general remedy for tiredness or aging. Agree on which symptoms and laboratory results will be followed and when the clinician will reassess benefit and adverse effects. Individual results vary.3
The risks and the 2025 FDA label change, without spin
Safety note
On February 28, 2025, the FDA issued class-wide labeling changes for testosterone products. Based on the TRAVERSE trial and required post-market blood-pressure studies, the agency removed the 2015 boxed warning about a possible increased risk of cardiovascular events. In its place, the labels carry a warning that testosterone can raise blood pressure, which itself is a cardiovascular risk factor.1
The fertility caveat every man should hear first
Testosterone treatment can suppress sperm production, sometimes severely. Reduced fertility has been reported and may be irreversible. Recovery cannot be promised or timed for an individual. Tell the clinician about plans for children before starting. The Endocrine Society recommends against starting testosterone when near-term fertility is planned.3, 4
Safety note
Fertility goals belong in the first visit, even if pregnancy is not an immediate plan. A clinician may recommend a reproductive-health evaluation before choosing treatment. Do not assume that a normal testosterone result while using TRT means normal sperm production, or that stopping alone will restore fertility on your preferred schedule.2
How to choose a responsible provider
Your next three steps
First, write down symptoms and when they started. Second, bring prior test results and a complete medication list. Third, discuss fertility, treatment goals, and follow-up before agreeing to a prescription. These details help the clinician investigate the cause rather than treating a number alone.
Decide with a clinician, and expect follow-up. If treatment is appropriate, pick a format together, talk through fertility first, and choose a provider that monitors and stays reachable.
Get your energy back, the right way
- Online visits with licensed physicians
- Sexual wellness, hair and fertility support
- Lab panels at member pricing
- FSA & HSA eligible with all plans

From price shown is the 12-month plan rate. Prices may vary.
Frequently asked questions
Was this helpful?
Keep reading
Men's Health
Men's Health
Men's Health
Men's Health
Men's Health
Men's Health

Sources
- FDA. Class-wide labeling changes for testosterone products, February 28, 2025. Accessed September 15, 2026. fda.gov
- Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. American Urological Association, 2018; validity confirmed 2024. Accessed September 15, 2026. auanet.org
- Endocrine Society. Testosterone Therapy in Men With Hypogonadism guideline, March 19, 2018. Accessed September 15, 2026. endocrine.org
- DailyMed. Kyzatrex testosterone undecanoate labeling, section 8.3, revised September 2025. Accessed September 15, 2026. dailymed.nlm.nih.gov